2013. Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis. Reumatismo. 65, 2 (May 2013), 75–78. DOI:https://doi.org/10.4081/reumatismo.2013.75.